Use of Ursodeoxycholic Acid and the Risk of Severe Coronavirus Disease 2019 in Elderly Patients with Viral Hepatitis

DOI record: { "DOI": "10.2169/internalmedicine.4856-24", "ISSN": [ "0918-2918", "1349-7235" ], "URL": "http://dx.doi.org/10.2169/internalmedicine.4856-24", "article-number": "4856-24", "author": [ { "affiliation": [ { "name": "Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Japan" }, { "name": "Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Japan" } ], "family": "Okushin", "given": "Kazuya", "sequence": "first" }, { "affiliation": [ { "name": "Department of Infectious Diseases, Graduate School of Medicine, The University of Tokyo, Japan" } ], "family": "Ikeuchi", "given": "Kazuhiko", "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Japan" } ], "family": "Saito", "given": "Makoto", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Infectious Diseases, Graduate School of Medicine, The University of Tokyo, Japan" } ], "family": "Kishida", "given": "Toshiyuki", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Japan" } ], "family": "Kado", "given": "Akira", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Japan" } ], "family": "Fujishiro", "given": "Mitsuhiro", "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infection Control and Prevention, Education Research Center, The Tokyo Health Care University, Japan" } ], "family": "Moriya", "given": "Kyoji", "sequence": "additional" }, { "affiliation": [ { "name": "Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Japan" } ], "family": "Yotsuyanagi", "given": "Hiroshi", "sequence": "additional" }, { "affiliation": [ { "name": "Kanto Central Hospital, Japan" } ], "family": "Koike", "given": "Kazuhiko", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Japan" }, { "name": "Department of Infectious Diseases, Graduate School of Medicine, The University of Tokyo, Japan" } ], "family": "Tsutsumi", "given": "Takeya", "sequence": "additional" } ], "container-title": "Internal Medicine", "container-title-short": "Intern. Med.", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2025, 1, 31 ] ], "date-time": "2025-01-31T22:13:45Z", "timestamp": 1738361625000 }, "deposited": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T03:32:58Z", "timestamp": 1738380778000 }, "indexed": { "date-parts": [ [ 2025, 2, 1 ] ], "date-time": "2025-02-01T05:33:49Z", "timestamp": 1738388029376, "version": "3.35.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025 ] ] }, "language": "en", "link": [ { "URL": "https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_4856-24/_pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "962", "original-title": [], "prefix": "10.2169", "published": { "date-parts": [ [ 2025 ] ] }, "published-print": { "date-parts": [ [ 2025 ] ] }, "publisher": "Japanese Society of Internal Medicine", "reference": [ { "DOI": "10.1016/S0140-6736(21)02796-3", "doi-asserted-by": "publisher", "key": "1", "unstructured": "1. Collaborators C-EM. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet 399: 1513-1536, 2022 (in eng)." }, { "DOI": "10.1038/s41467-024-51141-y", "ISSN": "https://id.crossref.org/issn/2041-1723", "author": "Z Li", "doi-asserted-by": "crossref", "first-page": "7033", "issn-type": "print", "journal-title": "Nature Communications", "key": "2", "unstructured": "2. Li Z, Hu P, Qu L, et al. Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022-2023) following a pivotal shift in the pandemic. Nature communications 15: 7033, 2024 (in eng).", "volume": "15", "year": "2024" }, { "DOI": "10.1038/s41591-024-03173-6", "doi-asserted-by": "publisher", "key": "3", "unstructured": "3. Al-Aly Z, Davis H, McCorkell L, et al. Long COVID science, research and policy. Nature medicine 30: 2148-2164, 2024 (in eng)." }, { "DOI": "10.1371/journal.pmed.1004428", "ISSN": "https://id.crossref.org/issn/1549-1277", "author": "WHK Schilling", "doi-asserted-by": "crossref", "first-page": "e1004428", "issn-type": "print", "journal-title": "PLoS Medicine", "key": "4", "unstructured": "4. Schilling WHK, Mukaka M, Callery JJ, et al. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial. PLoS medicine 21: e1004428, 2024 (in eng).", "volume": "21", "year": "2024" }, { "key": "5", "unstructured": "5. Brevini T, Maes M, Webb GJ, et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature 2022 (in eng)." }, { "DOI": "10.1111/joim.13630", "doi-asserted-by": "crossref", "key": "6", "unstructured": "6. John BV, Bastaich D, Webb G, et al. Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis. J Intern Med 293: 636-647, 2023 (in eng)." }, { "DOI": "10.2196/59274", "doi-asserted-by": "crossref", "key": "7", "unstructured": "7. Lee H, Kim MG, Yeom SW, et al. Association Between Ursodeoxycholic Acid and Clinical Outcomes in Patients With COVID-19 Infection: Population-Based Cohort Study. JMIR Public Health Surveill 10: e59274, 2024 (in eng)." }, { "DOI": "10.3390/v15081738", "doi-asserted-by": "crossref", "key": "8", "unstructured": "8. Colapietro F, Angelotti G, Masetti C, et al. Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients. Viruses 15: 2023 (in eng)." }, { "DOI": "10.1111/liv.15736", "doi-asserted-by": "publisher", "key": "9", "unstructured": "9. Marrone G, Covino M, Merra G, et al. Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts. Liver international : official journal of the International Association for the Study of the Liver 44: 83-92, 2024 (in eng)." }, { "DOI": "10.1002/jmv.29418", "ISSN": "https://id.crossref.org/issn/0146-6615", "author": "C Corpechot", "doi-asserted-by": "crossref", "first-page": "e29418", "issn-type": "print", "journal-title": "Journal of Medical Virology", "key": "10", "unstructured": "10. Corpechot C, Verdoux M, Frank-Soltysiak M, Duclos-Vallee JC, Grimaldi L. Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting. Journal of medical virology 96: e29418, 2024 (in eng).", "volume": "96", "year": "2024" }, { "DOI": "10.1111/joim.13704", "doi-asserted-by": "crossref", "key": "11", "unstructured": "11. Okushin K, Kurano M, Group U-US, et al. Ursodeoxycholic acid for coronavirus disease 2019 prevention. J Intern Med 295: 106-109, 2024 (in eng)." }, { "DOI": "10.3390/v15040930", "doi-asserted-by": "crossref", "key": "12", "unstructured": "12. Delgado JF, Vidal M, Julia G, et al. Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys ((R) ) Immunoassay in the S Protein Vaccination Era. Viruses 15: 2023 (in eng)." }, { "key": "13", "unstructured": "13. Medical Data Vision Co. L. MDV EBM insight. In: MDV EBM insight." }, { "DOI": "10.1016/j.je.2016.09.009", "doi-asserted-by": "crossref", "key": "14", "unstructured": "14. Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 27: 476-482, 2017 (in eng)." }, { "DOI": "10.37737/ace.1.3_76", "doi-asserted-by": "publisher", "key": "15", "unstructured": "15. Yasunaga H. Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database. Annals of Clinical Epidemiology 1: 76-79, 2019." }, { "DOI": "10.1016/j.diabres.2020.108346", "doi-asserted-by": "publisher", "key": "16", "unstructured": "16. Guo L, Shi Z, Zhang Y, et al. Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis. Diabetes research and clinical practice 166: 108346, 2020 (in eng)." }, { "DOI": "10.1038/s41440-020-0485-2", "doi-asserted-by": "crossref", "key": "17", "unstructured": "17. Huang S, Wang J, Liu F, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res 43: 824-831, 2020 (in eng)." }, { "DOI": "10.1186/s12985-021-01604-1", "doi-asserted-by": "crossref", "key": "18", "unstructured": "18. Liu Y, Pan Y, Yin Y, Chen W, Li X. Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis. Virol J 18: 157, 2021 (in eng)." }, { "DOI": "10.1016/j.eclinm.2020.100515", "doi-asserted-by": "crossref", "key": "19", "unstructured": "19. Attaway AA, Zein J, Hatipoglu US. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry. EClinicalMedicine 26: 100515, 2020 (in eng)." }, { "DOI": "10.1016/j.jiac.2023.12.006", "doi-asserted-by": "publisher", "key": "20", "unstructured": "20. Kutsuna S, Onozuka D, Asano K, Matsunami K, Matsuoka T. Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka prefecture, Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 30: 511-515, 2024 (in eng)." }, { "key": "21", "unstructured": "21. Ministry of Health, Labour and Welfare. Visualizing the data: information on COVID-19 infections [Internet]. [cited 2024 Sep 16]. Available from: https://covid19.mhlw.go.jp/en/." }, { "DOI": "10.1186/s12879-021-06536-3", "ISSN": "https://id.crossref.org/issn/1471-2334", "author": "ZG Dessie", "doi-asserted-by": "crossref", "first-page": "855", "issn-type": "print", "journal-title": "BMC Infectious Diseases", "key": "22", "unstructured": "22. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC infectious diseases 21: 855, 2021 (in eng).", "volume": "21", "year": "2021" }, { "DOI": "10.1128/spectrum.01150-22", "doi-asserted-by": "crossref", "key": "23", "unstructured": "23. Domovitz T, Ayoub S, Werbner M, et al. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State. Microbiol Spectr 10: e0115022, 2022 (in eng)." }, { "DOI": "10.1016/j.compbiomed.2021.104219", "doi-asserted-by": "crossref", "key": "24", "unstructured": "24. Singh MK, Mobeen A, Chandra A, Joshi S, Ramachandran S. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection? Comput Biol Med 130: 104219, 2021 (in eng)." }, { "DOI": "10.1002/hsr2.2207", "doi-asserted-by": "crossref", "key": "25", "unstructured": "25. Shaikh OS, Yan P, Rogal S, Butt AA. The impact of COVID-19 on the clinical course and outcome of patients with cirrhosis: An observational study. Health Sci Rep 7: e2207, 2024 (in eng)." }, { "key": "26", "unstructured": "26. Ge J, Far AT, Digitale JC, Pletcher MJ, Lai JC; National CCCC. Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 (in eng)." }, { "DOI": "10.1007/s40801-022-00296-5", "doi-asserted-by": "crossref", "key": "27", "unstructured": "27. Laurent T, Simeone J, Kuwatsuru R, et al. Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center. Drugs Real World Outcomes 9: 175-187, 2022 (in eng)." } ], "reference-count": 27, "references-count": 27, "relation": {}, "resource": { "primary": { "URL": "https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_4856-24/_article" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Use of Ursodeoxycholic Acid and the Risk of Severe Coronavirus Disease 2019 in Elderly Patients with Viral Hepatitis", "type": "journal-article" }